Skip to main content Skip to main menu
UF Health University of Florida
Division of Infectious Diseases & Global Medicine Department of Medicine in the College of Medicine
Make an appointment
Ammara Mushtaq

Ammara Mushtaq, MD

Clinical Assistant Professor

Department: MD-INFECTIOUS DISEASES
Business Phone: (352) 294-5481
Business Email: ammara.mushtaq@medicine.ufl.edu

About Ammara Mushtaq

Dr. Mushtaq specializes in treatment of general infectious diseases and HIV. Dr. Mushtaq has special interest in treatment of difficult-to treat bacterial infections causing pneumonia, bacteremia, meningitis, skin and soft tissue infections, osteomyelitis, endocarditis and septic arthritis, among others. Other clinical interests include healthcare-associated infections, sepsis, and outpatient parenteral antibiotic therapy (OPAT).

Dr. Mushtaq’s research interests are to understand epidemiology, diagnosis and therapeutics of infections caused by multidrug-resistant Gram-negative bacteria, and antimicrobial stewardship. She collaborates with genomic scientists and microbiologists to understand the genetic context of such drug-resistant bacteria. She has international outreach and collaborations with researchers in the UK and Pakistan to address some of the key questions to improve our understanding of how antibiotic resistant Gram-negative bacteria spread and cause infections. Her current efforts are focused on developing an antimicrobial resistance surveillance network in Southeast Asia. Dr. Mushtaq’s work has been published in reputed journals and books, and has been cited.

Accomplishments

Ambulatory resident of the year
2016-2017 · Department of Medicine, Detroit Medical Center
ASM Student and Postdoc travel grant for ASM Microbe 2016
2016 · American Society of Microbiology
Elected to participate in 64th Lindau Nobel Laureates Meeting in Medicine or Physiology
2014 · Lindau Council, Germany
Irfan A. Khan Memorial Merit Award for outstanding dedication in the field of medicine
2014 · Dow Graduate Association of North America (DOGANA)
Overseas scholarship
2012 · British Society of Antimicrobial Chemotherapy for researchCardiff University, UK

Board Certifications

  • Infectious Diseases
    American Board of Internal Medicine
  • Internal Medicine
    American Board of Internal Medicine

Clinical Profile

Specialties
  • Infectious Disease
Areas of Interest
  • Asymptomatic HIV infection
  • Asymptomatic bacteriuria
  • Bacterial gastroenteritis
  • Blood culture
  • Cellulitis
  • Ear infection – acute
  • Ear infection – chronic
  • Endocarditis
  • Epidural abscess
  • Gram-negative meningitis
  • Infectious endocarditis
  • Osteomyelitis
  • Pseudomembranous colitis
  • Sepsis
  • Septic arthritis
  • Septic shock
  • Sexually Transmitted Diseases (STD)
  • Sputum Gram stain
  • Surgical wound infection – treatment
  • Urinary tract infection – adults

Research Profile

Areas of Interest
  • Antimicrobial stewardship
  • Development of novel antibiotics
  • Dual-carbapenemase producing bacteria
  • Metallo-β-lactamase producing Gram-negative bacteria
  • Pathogenesis of carbapenem-resistant Enterobacterales
  • Pseudomonas aeruginosa and Acinetobacter baumannii
  • Surveillance of antimicrobial resistance in developing countries

Publications

Academic Articles
2025
Maria Eugenia Toledo-Romani-doing a lot with the least.
The Lancet. Infectious diseases. 25(1) [DOI] 10.1016/S1473-3099(24)00821-1. [PMID] 39734083.
PubMed · Publisher’s Site
2024
Alemnew Dagnew-developing a new TB vaccine.
The Lancet. Infectious diseases. 24(4) [DOI] 10.1016/S1473-3099(24)00163-4. [PMID] 38519258.
PubMed · Publisher’s Site
2024
Lise Musset- studying antimalarial resistance in America.
The Lancet. Infectious diseases. 24(8) [DOI] 10.1016/S1473-3099(24)00442-0. [PMID] 39059838.
PubMed · Publisher’s Site
2024
Nuria Izquierdo-Useros-fighting the good fight.
The Lancet. Infectious diseases. 24(5) [DOI] 10.1016/S1473-3099(24)00241-X. [PMID] 38670676.
PubMed · Publisher’s Site
2023
A new antifungal drug for candidaemia.
The Lancet. Infectious diseases. 23(6) [DOI] 10.1016/S1473-3099(23)00307-9. [PMID] 37244278.
3 citations · PubMed · Publisher’s Site
2023
CROI 2023.
The Lancet. Infectious diseases. 23(4) [DOI] 10.1016/S1473-3099(23)00150-0. [PMID] 36965497.
PubMed · Publisher’s Site
2023
Highlights from SHEA 2023.
The Lancet. Infectious diseases. 23(6) [DOI] 10.1016/S1473-3099(23)00303-1. [PMID] 37244274.
PubMed · Publisher’s Site
2023
John Schieffelin-fighting viral haemorragic fevers.
The Lancet. Infectious diseases. 23(11) [DOI] 10.1016/S1473-3099(23)00639-4. [PMID] 37839423.
PubMed · Publisher’s Site
2023
Lenacapavir: a new treatment of resistant HIV-1 infections.
The Lancet. Infectious diseases. 23(3) [DOI] 10.1016/S1473-3099(23)00075-0. [PMID] 36841248.
3 citations · PubMed · Publisher’s Site
2023
Marta Boffito-The happy warrior.
The Lancet. Infectious diseases. 23(8) [DOI] 10.1016/S1473-3099(23)00441-3. [PMID] 37507152.
PubMed · Publisher’s Site
2023
Minoarisoa Rajerison-fighting plague in Madagascar.
The Lancet. Infectious diseases. 23(2) [DOI] 10.1016/S1473-3099(22)00860-X. [PMID] 36549310.
PubMed · Publisher’s Site
2023
Sulbactam-durlobactam for Acinetobacter pneumonia.
The Lancet. Infectious diseases. 23(8) [DOI] 10.1016/S1473-3099(23)00450-4. [PMID] 37516133.
PubMed · Publisher’s Site
2022
“It’s worth a shot… or is it?” Notes from the grassroots on vaccine hesitancy and bridging gaps.
Infection control and hospital epidemiology. 43(11):1750-1752 [DOI] 10.1017/ice.2021.356. [PMID] 34338180.
1 citation · PubMed · Publisher’s Site
2022
Alexandra King-promoting Indigenous self-determination.
The Lancet. Infectious diseases. 22(2) [DOI] 10.1016/S1473-3099(22)00019-6. [PMID] 35092799.
PubMed · Publisher’s Site
2022
ASM Microbe 2022.
The Lancet. Infectious diseases. 22(8) [DOI] 10.1016/S1473-3099(22)00457-1. [PMID] 35870458.
PubMed · Publisher’s Site
2022
Cheryl Cohen-promoting evidence-based health policy.
The Lancet. Infectious diseases. 22(3) [DOI] 10.1016/S1473-3099(22)00078-0. [PMID] 35218755.
PubMed · Publisher’s Site
2022
Infectious diseases compensation in the USA: the relative value.
The Lancet. Infectious diseases. 22(8):1106-1108 [DOI] 10.1016/S1473-3099(22)00360-7. [PMID] 35716701.
6 citations · PubMed · Publisher’s Site
2022
Najwa Khuri-Bulos-leading paediatric care in the Arab world.
The Lancet. Infectious diseases. 22(6) [DOI] 10.1016/S1473-3099(22)00298-5. [PMID] 35643109.
PubMed · Publisher’s Site
2022
SHEA Spring Conference 2022.
The Lancet. Infectious diseases. 22(6) [DOI] 10.1016/S1473-3099(22)00300-0. [PMID] 35643101.
PubMed · Publisher’s Site
2022
Updates in pre-exposure prophylaxis for HIV.
The Lancet. Infectious diseases. 22(3) [DOI] 10.1016/S1473-3099(22)00081-0. [PMID] 35218750.
1 citation · PubMed · Publisher’s Site
2022
Updates in sepsis management.
The Lancet. Infectious diseases. 22(1) [DOI] 10.1016/S1473-3099(21)00773-8. [PMID] 34953551.
13 citations · PubMed · Publisher’s Site
2021
CROI 2021.
The Lancet. Infectious diseases. 21(5) [DOI] 10.1016/S1473-3099(21)00214-0. [PMID] 33894841.
1 citation · PubMed · Publisher’s Site
2021
ECCMID 2021.
The Lancet. Infectious diseases. 21(9) [DOI] 10.1016/S1473-3099(21)00487-4. [PMID] 34450069.
PubMed · Publisher’s Site
2021
IDWeek 2021.
The Lancet. Infectious diseases. 21(11) [DOI] 10.1016/S1473-3099(21)00634-4. [PMID] 34717807.
PubMed · Publisher’s Site
2021
Loretta Sweet Jemmott-a voice for the voiceless.
The Lancet. Infectious diseases. 21(6) [DOI] 10.1016/S1473-3099(21)00282-6. [PMID] 34051191.
PubMed · Publisher’s Site
2021
New guidelines for Lyme disease diagnosis.
The Lancet. Infectious diseases. 21(2) [DOI] 10.1016/S1473-3099(21)00009-8. [PMID] 33515521.
PubMed · Publisher’s Site
2021
Primary care of patients with HIV.
The Lancet. Infectious diseases. 21(1) [DOI] 10.1016/S1473-3099(20)30925-7. [PMID] 33271066.
PubMed · Publisher’s Site
2021
SHEA Spring 2021.
The Lancet. Infectious diseases. 21(6) [DOI] 10.1016/S1473-3099(21)00276-0. [PMID] 34051185.
PubMed · Publisher’s Site
2021
Updates on management of STIs.
The Lancet. Infectious diseases. 21(10) [DOI] 10.1016/S1473-3099(21)00572-7. [PMID] 34562397.
PubMed · Publisher’s Site
2021
World Microbe Forum 2021.
The Lancet. Infectious diseases. 21(8) [DOI] 10.1016/S1473-3099(21)00409-6. [PMID] 34331880.
PubMed · Publisher’s Site
2020
IDWeek 2020.
The Lancet. Infectious diseases. 20(12) [DOI] 10.1016/S1473-3099(20)30875-6. [PMID] 33248035.
PubMed · Publisher’s Site
2020
New guidelines for latent tuberculosis.
The Lancet. Infectious diseases. 20(4) [DOI] 10.1016/S1473-3099(20)30181-X. [PMID] 32222207.
2 citations · PubMed · Publisher’s Site
2020
New guidelines to treat bacterial infections.
The Lancet. Infectious diseases. 20(11) [DOI] 10.1016/S1473-3099(20)30799-4. [PMID] 33098778.
1 citation · PubMed · Publisher’s Site
2019
Pulmonary complications of influenza infection: a targeted narrative review.
Postgraduate medicine. 131(5):299-308 [DOI] 10.1080/00325481.2019.1592400. [PMID] 30845866.
18 citations · PubMed · Publisher’s Site
2019
Repeating blood cultures after initial bacteremia: When and how often?
Cleveland Clinic journal of medicine. 86(2):89-92 [DOI] 10.3949/ccjm.86a.18001. [PMID] 30742578.
7 citations · PubMed · Publisher’s Site
2018
Comparison of complications in midlines versus central venous catheters: Are midlines safer than central venous lines?
American journal of infection control. 46(7):788-792 [DOI] 10.1016/j.ajic.2018.01.006. [PMID] 29525366.
31 citations · PubMed · Publisher’s Site
2018
Impact of a Multidisciplinary Infection Prevention Initiative on Central Line and Urinary Catheter Utilization in a Long-term Acute Care Hospital.
Open forum infectious diseases. 5(7) [DOI] 10.1093/ofid/ofy156. [PMID] 30090837.
6 citations · PubMed · Publisher’s Site
2018
In Vitro Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli
Antimicrob Agents Chemother. 62(8):e00533-18
2018
New clinical recommendations for Clostridium difficile.
The Lancet. Infectious diseases. 18(4) [DOI] 10.1016/S1473-3099(18)30180-4. [PMID] 29582768.
3 citations · PubMed · Publisher’s Site
2017
Implementing an antibiotic stewardship program at a long-term acute care hospital in Detroit, Michigan.
American journal of infection control. 45(12):e157-e160 [DOI] 10.1016/j.ajic.2017.07.028. [PMID] 29031431.
9 citations · PubMed · Publisher’s Site
2017
Updates in tuberculosis diagnosis in the USA.
The Lancet. Infectious diseases. 17(2):147-148 [DOI] 10.1016/S1473-3099(17)30018-X. [PMID] 28134117.
3 citations · PubMed · Publisher’s Site
2016
Clinical significance of coryneform Gram-positive rods from blood identified by MALDI-TOF mass spectrometry and their susceptibility profiles – a retrospective chart review
Diagn Microbiol Infect Dis .. 85(3):372-376
2016
Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva
Antimicrob Agents Chemother. 60(8):5036-5039
2016
FDA approves broad hepatitis C treatment.
The Lancet. Infectious diseases. 16(10):1118-1119 [DOI] 10.1016/S1473-3099(16)30344-9. [PMID] 27676353.
PubMed · Publisher’s Site
2016
Highlights from ASM Microbe 2016.
The Lancet. Infectious diseases. 16(8):898-9 [DOI] 10.1016/S1473-3099(16)30225-0. [PMID] 27477984.
PubMed · Publisher’s Site
2016
Highlights from the 26th ECCMID.
The Lancet. Infectious diseases. 16(6):645-647 [DOI] 10.1016/S1473-3099(16)30094-9. [PMID] 27301925.
1 citation · PubMed · Publisher’s Site
2016
Training in infectious diseases-any takers?
The Lancet. Infectious diseases. 16(6):648-649 [DOI] 10.1016/S1473-3099(16)30095-0. [PMID] 27301926.
1 citation · PubMed · Publisher’s Site
2016
UN commits to tackling antimicrobial resistance.
The Lancet. Infectious diseases. 16(11):1229-1230 [DOI] 10.1016/S1473-3099(16)30419-4. [PMID] 27788986.
9 citations · PubMed · Publisher’s Site
2015
Highlights from the 25th ECCMID.
The Lancet. Infectious diseases. 15(6):639-40 [DOI] 10.1016/S1473-3099(15)00010-9. [PMID] 26008841.
PubMed · Publisher’s Site
2014
Characterization of plasmids in extensively drug-resistant acinetobacter strains isolated in India and Pakistan
Antimicrob Agents Chemother. 59(2):923-929
2013
Current efficacy of antibiotics against Klebsiella isolates from urine samples – a multi-centric experience in Karachi.
Pakistan journal of pharmaceutical sciences. 26(1):11-5 [PMID] 23261722.
8 citations · PubMed
2012
Frequency of HBsAg positivity: a laboratory data analysis.
Journal of the College of Physicians and Surgeons–Pakistan : JCPSP. 22(11):742-3 [PMID] 23146863.
PubMed
2012
Hand hygiene does work.
The Lancet. Infectious diseases. 12(11):828-9 [DOI] 10.1016/S1473-3099(12)70235-9. [PMID] 23099078.
2 citations · PubMed · Publisher’s Site

Grants

Jan 2023 – Oct 2023
The Burden of Antibiotic Resistance in Neonates from Developing Societies (BARNARDS) and 2) : The Burden of Antimicrobial Resistance and Antibiotic Treatment Failure in Low-, Middle- and High-Income Countries (BALANCE)
Role: Principal Investigator
Funding: UNIVERSITY OF OXFORD

Education

Fellowship – Infectious diseases
2019-2021 · Icahn School of Medicine at Mount Sinai, New York
Residency – Internal Medicine
2016-2019 · Wayne State University/Detroit Medical Center
Research Trainee – Infectious diseases
2015-2016 · Infectious Diseases Research Laboratory at Mayo Clinic, Rochester
Medical Degree
2009-2015 · Dow Medical College, Dow University of Health Sciences, Pakistan

Contact Details

Phones:
Business:
(352) 294-5481
Emails:
Business:
ammara.mushtaq@medicine.ufl.edu
Addresses:
Business Mailing:
PO Box 100289
 GAINESVILLE FL 32610
Business Street:
1600 SW ARCHER RD
 GAINESVILLE FL 32610